Crism Therapeutics Corporation Ord Npv (CRTX)

Sector:

Investment Firms

Index:

FTSE AIM All-Share

 22.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 24.00
  • 52 Week Low: 21.88
  • Currency: UK Pounds
  • Shares Issued: 32.68m
  • Volume: 10,640
  • Market Cap: £7.35m

CRTX Overview

Founded in March 2016, CRISM Therapeutics employs an interdisciplinary team of pharmaceutical specialists based in Birmingham. We serve a wide range of international clients, aiming to improve the clinical performance of active pharmaceutical ingredients (APIs) via local drug delivery and personalised medicines.

Key Personnel

CEO: Andrew James Webb
Chief Scientific Officer: Christopher McConville
Independent Non-Executive Director: Gerald Beaney
Non-Executive Chairman: Nermeen Yunus Varawalla
Non-Executive Dir:

Contact Details

Address: Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands, USA,
Phone: +1 (925) 408 4621
Website: http://www.crismtherapeutics.com/

Listings

Sector: Investment Firms(LSE)
Index: FTSE AIM All-Share
ISIN: VGG042401262

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CRTX Market Data

Currency UK Pounds
Share Price 22.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 24.00
52 Week Low 21.88
Volume 10,640
Shares Issued 32.68m
Market Cap £7.35m

CRTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Value Not Available
Income Not Available
Growth Not Available

CRTX Dividends

  Latest Previous
  Special Interim
Ex-Div 01-Jun-23 n/a
Paid 14-Jun-23 n/a
Amount 1.80p 0.000¢

Trades for 12-Jun-2025

Time Volume / Share Price
09:01 11 @ 21.88p
08:33 10,504 @ 23.80p
08:33 125 @ 24.00p

CRTX Key Personnel

CEO Andrew James Webb

Top of Page